and Patient Support
Best Truse Experts Latest Laboratory Technlogy
It is a long established fact that a reader will be distracted by the readable content of a page when at layout The point of using Ipsum.
- Quisque non neque posuere, gravida arcu sed, laoreet tellus.
- Etiam iaculis velit sed vestibulum, non pretium pellentesque.
- Integer luctus nunc ut nulla elementum, quis ultrices viverra.
We Have 50+ Years Of Experiences For Give You Better Quality Results.
Explore Our Main Service
Chemical Research
Chemical Research is simply dummy text of the printing infancy and typesetting industry text Lorem Ipsum has been the industry’s
pathology testing
pathology testing is simply dummy text of the printing infancy and typesetting industry text Lorem Ipsum has been the industry’s
chemical formula
chemical formula is simply dummy text of the printing infancy and typesetting industry text Lorem Ipsum has been the industry’s
Best Truse Experts Laboratory Technlogy

Dr. John Deo
Laboratory Managers
WE ARE TRUSTED BY WORLD'S LEADING COMPANIES
All The Gret Work That We Done
We’ll Ensure You Always Get The Best Result
Our Workig Best Processs
Explane Projects
There are many varios passages
suffered alten in some
Generate Proposal
There are many varios passages
suffered alten in some
Testing Begins
There are many varios passages
suffered alten in some
Reports Delivered
There are many varios passages
suffered alten in some
What Our Client happy Say About Us
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even believable.
Dr. john Martin
Cancer ResearchThere are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even believable.
Dr. john Martin
Cancer ResearchThere are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even believable.
Dr. john Martin
Cancer ResearchThere are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even believable.
Dr. john Martin
Cancer ResearchBook Your Visit Now
1
+Our Happy Clients
1
+Professional Staff
1
+Year OF Experience
1
+Lab TEchbicians
see Our Latest Blog
- admin
- News
Rare Disease Day 2026
Approximately 300 million people are living today with rare diseases. Neutropenia is a rare disease, but still it exists! All the Neutro-NARPS team and Working Groups Members join forces to better understand the pathophysiology and provide the best support for the diagnosis and treatment of patients living with neutropenia. Neutro-NARPS supports Rare Disease Day 2026!
- admin
- News
International Day of Women and Girls in Science
On the International Day of Women and Girls in Science, we highlight Professor Papadaki’s leading role in research on neutropenia and bone marrow failure syndromes.
- admin
- News
NEUTRO-NARPS 1st Working Groups Meeting Successfully Held
The NEUTRO-NARPS 1st Working Groups Meeting, held on 23rd January 2026, was completed with great success, bringing together more than 100 members from across the network in a highly engaging virtual event.
- admin
- News
Open Call for Grants
Application Period 12/01/26 – 28/01/2026We would like to announce the first open call for Grants, funded by our COST Action NEUTRO-NARPS (CA24124): Read more..
- admin
- News
1st WORKING GROUPS MEETING
Friday, 23rd January 2026
Virtual Meeting
AGENDA outline (time zone CET)
- admin
- News
Season’s Greetings
Happy Holidays and best wishes for a Happy New Year from all of us in NEUTRO-NARPS.Wishing you and your families peace, joy, and success.
- admin
- News
It’s official!
Our COST ACTION’s kick-off meeting took place on Friday 24th Ocrober, in Brussels!What a fruitful day it was. Lots of discussions, brainstorming and plans for our future steps.So many familiar faces and new ones that we welcome to the neutropenia community.The journey has just begun. Stay tuned!!!
- admin
- News
Kick-off Meeting
COST Action CA24124 – Network for the Advancement of Neutropenia Research and Patient Support (Neutro-NARPS) The Kick-off Meeting of the Neutro-NARPS (CA24124) Action will take place in Brussels, on October 24, 2025, at the COST Association Office. This marks the official launch of the Network for the Advancement of Neutropenia Research and Patient Support (Neutro-NARPS) […]
- admin
- News
Get to Know Us & Connect with Neutro-NARPS
We are excited to welcome you to the official online presence of Neutro-NARPS – Network for the Advancement of Neutropenia Research and Patient Support (COST Action CA24124)! Neutro-NARPS is a European network of scientists, clinicians, patient representatives, and industry partners dedicated to improving the understanding, diagnosis, and treatment of Chronic Neutropenia (CNP) — a rare […]
- admin
- News
Welcome to Neutro‑NARPS – COST Action CA24124
We are delighted to announce the launch of Neutro-NARPS (CA24124) – Network for the Advancement of Neutropenia Research and Patient Support, a new COST Association Action. The formal approval date was 19 May 2025 and the Action runs from 24 October 2025 until 23 October 2029. Who we are Neutro-NARPS brings together a multidisciplinary consortium […]